Swedish Drug-elution Trial in Peripheral Arterial Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3556 participants.

Also called NCT02051088

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,556 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02051088
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02051088. Randomized; single masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2025-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Swedish Drug-elution Trial in Peripheral Arterial Disease
Acronym
SWEDEPAD
Condition
Peripheral Arterial Disease
Condition
Critical Limb Ischemia
Intervention (Procedure)
Revascularization with drug-eluting technology
Intervention (Procedure)
Revascularization without drug-eluting technology
Intervention (Device)
drug-coated balloons and/or drug-eluting stents
Lead sponsor
Sahlgrenska University Hospital (class: other)
Collaborator
The Swedish Research Council (class: other government)
Collaborator
Swedish Heart Lung Foundation (class: other)
Collaborator
Uppsala University (class: other)
Collaborator
The Swedish National Registry for Vascular Surgery (class: other)

Record details

Record id
cardio:ct-nct02051088
Content hash
027701b8bb06c8bd7ac90328e1a47508911ba30dc7e833a9e8576fdd4dc12a4d